Publication

Article

BioPharm International

BioPharm International-03-02-2011
Volume2011 Supplement
Issue 2

BioPharm International, March 2011 Supplement (PDF)

Global Outsourcing

To view a PDF of this article from the BioPharm International archives, click this link

Articles in this issue
Sidebar_t-711284-1408621012852.jpg
Supply-Chain Transformation: Strategic Necessity for the Life Sciences
Carrier_Figure-2-711282-1408621018203.jpg
Key Considerations When Outsourcing Cell-Culture Medium Development
Abraham_Figure1-711283-1408621016004.jpg
Successful Technology Transfer, Process Validation, and Partnership with a CMO
BP0311suppBolonFigures_2-711281-1408621021555.jpg
Sponsor-CMO Conflict Management for Clinical-Phase Biologics
BioPharm International, March 2011 Supplement (PDF)

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Related Content
PRAGUE, CZECHIA - NOVEMBER 1, 2019: Astellas logo in front of their main office for Prague. Astellas Pharma is a Japanese Pharmaceutical company spread worldwide | Image Credit: © Jerome - stock.adobe.com
August 21st 2025

Astellas and Pfizer Bladder Cancer Therapy Recommended by UK’s NICE

Patrick Lavery
The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
August 21st 2025

The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game

G-CON
Bio/Pharma's Response to Tariff and Trade Policy
August 21st 2025

Bio/Pharma's Response to Tariff and Trade Policy: Survey Results

Christopher Cole
Mastering Antibody-Drug Conjugates
August 21st 2025

Mastering Antibody-Drug Conjugates

BIOVECTRA
The front of the REGENXBIO facility in Rockville, Montgomery County, Maryland. REGENXBIO is a biotechnology company researching Adeno-Associate Virus (AAV) gene therapy | Image Credit: © MJ Kerr - stock.adobe.com
August 21st 2025

FDA Extends Review Period for REGENXBIO Hunter Syndrome Treatment

Patrick Lavery
Lung cancer, 3D illustration and photo under microscope. Histopathology light micrograph of small cell lung cancer | Image Credit: © Dr_Microbe - © Dr_Microbe - stock.adobe.com
August 21st 2025

Merck and Daiichi Sankyo’s I-DXd Earns FDA Breakthrough Therapy Status in Small Cell Lung Cancer

Feliza Mirasol
© 2025 MJH Life Sciences

All rights reserved.